Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Parallel Group, Double-blind Trial to Evaluate Different Dose Combinations of Lercanidipine and Enalapril in Comparison With Each Component Administered Alone and With Placebo in Patients With Essential Hypertension

NCT01093807 is registered in ClinicalTrials.gov with RECORDATI GROUP as lead sponsor.

NCT NCT01093807
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01093807 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Parallel Group, Double-blind Trial to Evaluate Different Dose Combinations of Lercanidipine and Enalapril in Comparison With Each Component Administered Alone and With Placebo in Patients With Essential Hypertension
Lead sponsor
RECORDATI GROUP
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2010
Completion date
April 30, 2011
Enrollment
1,039 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

essential hypertension